RU2010129032A - METHOD FOR INCREASING PROLIFERATIVE ACTIVITY OF PERIPHERAL BLOOD LYMPHOCYTES - Google Patents
METHOD FOR INCREASING PROLIFERATIVE ACTIVITY OF PERIPHERAL BLOOD LYMPHOCYTES Download PDFInfo
- Publication number
- RU2010129032A RU2010129032A RU2010129032/15A RU2010129032A RU2010129032A RU 2010129032 A RU2010129032 A RU 2010129032A RU 2010129032/15 A RU2010129032/15 A RU 2010129032/15A RU 2010129032 A RU2010129032 A RU 2010129032A RU 2010129032 A RU2010129032 A RU 2010129032A
- Authority
- RU
- Russia
- Prior art keywords
- nle
- peripheral blood
- proliferative activity
- ala ser
- tyr lys
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Способ повышения пролиферативной активности лимфоитов периферической крови, заключающийся в применении синтетического средства, в лекарственной основе, согласно изобретения, в качестве синтетического средства используют синтетические пептиды, имеющие структуру от LYS GLY PRO LEY THR NLE NLE ALA SER HIS TYR LYS GLN HIS CYS PRO и до THR NLE NLE ALA SER HIS TYR LYS GLN HIS CYS PRO, м.м. от 1794 до 1397 дальтон, в концентрациях от 10-4 до 10-5 мг/мл лекарственной основы, в качестве которой используют физиологический раствор, применяют один раз в сутки. A method of increasing the proliferative activity of peripheral blood lymphoids, which consists in using a synthetic agent in a drug basis, according to the invention, using synthetic peptides having a structure from LYS GLY PRO LEY THR NLE NLE ALA SER HIS TYR LYS GLN HIS CYS PRO and up to a synthetic agent THR NLE NLE ALA SER HIS TYR LYS GLN HIS CYS PRO, m. from 1794 to 1397 daltons, in concentrations from 10-4 to 10-5 mg / ml of the drug base, which is used as a physiological solution, is used once a day.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2010129032/15A RU2465001C2 (en) | 2010-07-13 | 2010-07-13 | Method for increasing proliferative activity of peripheral blood lymphocytes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2010129032/15A RU2465001C2 (en) | 2010-07-13 | 2010-07-13 | Method for increasing proliferative activity of peripheral blood lymphocytes |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2010129032A true RU2010129032A (en) | 2012-01-20 |
RU2465001C2 RU2465001C2 (en) | 2012-10-27 |
Family
ID=45785281
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2010129032/15A RU2465001C2 (en) | 2010-07-13 | 2010-07-13 | Method for increasing proliferative activity of peripheral blood lymphocytes |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2465001C2 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2080120C1 (en) * | 1994-07-19 | 1997-05-27 | Совместное русско-американское акционерное общество закрытого типа "Неофарм" | Agent showing immunomodulating activity |
EP1855724A2 (en) * | 2005-02-01 | 2007-11-21 | Research Development Foundation | Blys fusion proteins for targeting blys receptor and methods for treatment of b-cell proliferative disorders |
-
2010
- 2010-07-13 RU RU2010129032/15A patent/RU2465001C2/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2465001C2 (en) | 2012-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ592509A (en) | HLA-A*1101-restricted WTI peptide and pharmaceutical composition comprising the same | |
BR112016029848A2 (en) | mic-1 fusion proteins and uses thereof | |
FI3430027T3 (en) | Peptide for use in immunotherapy against non-small cell lung cancer and small cell lung cancer | |
EA201101706A1 (en) | Drug medication based on diyndolylmethanum (DIM) with enhanced bioavailability and its use in the treatment of hyperplastic and inflammatory diseases | |
MX2009007267A (en) | An insulinotropic complex using an immunoglobulin fragment. | |
EA201491605A1 (en) | WAYS TO IMPROVE THE DIAPHRAGM FUNCTION | |
PE20121393A1 (en) | PEPTIDE ANALOGUE OF OXYNTHOMODULIN | |
CY1120618T1 (en) | ANALOGUES OF COMPETITIVE MU OPIODIC RECEPTORS OF ENDOMORPHIN | |
NZ608502A (en) | Polypeptides that bind to human complement component c5 | |
CO6351689A2 (en) | PHARMACEUTICAL FORMULATIONS CONTAINING LEGANDS OF DOPAMINE RECEIVERS | |
RU2015102772A (en) | Benzodiazelipas for small cell lung cancer | |
EA200700976A1 (en) | COMPOUNDS IN THE FORM OF MOLECULE-CONJUGATES, HAVING ENHANCED ACTIVITY WITH RESPECT TO THE INCLUSION OF CELL | |
WO2011156453A3 (en) | Therapeutic peptides | |
RU2012157683A (en) | INSULIN DERIVATIVES CONTAINING ADDITIONAL DISULPHIDE LINKS | |
EA201490901A1 (en) | LINKERS BASED ON TYROSINE FOR FREE CONNECTION OF PEPTIDE | |
PE20142275A1 (en) | IL-17 ANTIBODY FORMULATION | |
RU2013146690A (en) | CYCLIC PEPTIDES WITH ANTINEOPLASTIC AND ANTI-ANGIONENOUS ACTIVITY | |
CY1115629T1 (en) | USE OF TROP Peptide Compounds and Pharmaceutical Compositions in Anemia Therapy | |
RU2015116264A (en) | COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE IN PATIENTS WITH DIABETES | |
MX349364B (en) | Novel alpha 1-antitrypsin variant, preparation method thereof, and use thereof. | |
EA201390722A1 (en) | CANCER TREATMENT BY IMPROVED DOSES OF SOLUBLE PROTEINS OF FGFR1 MERGER | |
EA201401148A1 (en) | BIOLOGICAL ACTIVE PEPTIDE COMPLEXES | |
UA109544C2 (en) | PHARMACEUTICAL COMPOSITION CONTAINING PARACETAMOL AND METHOD OF MANUFACTURING | |
RU2010129032A (en) | METHOD FOR INCREASING PROLIFERATIVE ACTIVITY OF PERIPHERAL BLOOD LYMPHOCYTES | |
EP4218786A3 (en) | Opiorphin for use as analgesic agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20130714 |